Journal of Clinical Oncology (JCO) Podcast
Episodes
Characterizing the Patterns of Clonal Evolution in Ibrutinib-Treated CLL: A Roadmap for Continued Progress
13 Feb 2017
Contributed by Lukas
Dr. Wiestner highlights characteristics of ibrutinib resistant CLL as reported by Woyach and colleagues and discusses how these data refine the manage...
Prevalence of Germline Mutations in Individuals With Colorectal Cancer as Determined Using a Multi-Gene Panel Test
30 Jan 2017
Contributed by Lukas
Summary and discussion of JCO paper by Yurgelun at al. using a 25-gene panel to demonstrate a nearly 10% germline mutation rate in colorectal cancer p...
Financial Barriers to Cancer Care for Patients Obtaining Insurance on the Federal Exchange
11 Jan 2017
Contributed by Lukas
By Stacie B. Dusetzina Considering the role of network coverage on access to accredited cancer institutions and potential out-of-pocket costs for pat...
Mindfulness-Based Interventions in Oncology: Not for Everyone?
21 Nov 2016
Contributed by Lukas
By Linda E. Carlson This podcast discusses the target study in the context of other research on mindfulness-based interventions for cancer patients an...
The Impact of Oral Targeted Therapies on the Cost of Care for Patients With Chronic Lymphocytic Leukemia
21 Nov 2016
Contributed by Lukas
By Christopher R. Flowers Modeling studies like the one presented by Qiushi Chen and colleagues can project where needs and opportunities exist to add...
Watching Nivolumab's Balancing Act: How Immune Activation May Affect Both Safety and Efficacy in Patients With Advanced Melanoma
14 Nov 2016
Contributed by Lukas
This podcast provides commentary on a large dataset describing the expected frequency, severity and kinetics of immune-related adverse events associat...
Getting to the Heart of the Matter: Biomarkers for the Assessment of Trastuzumab-Induced Cardiac Dysfunction
26 Oct 2016
Contributed by Lukas
By Deepa Rangachari This podcast focuses on the use of trastuzumab in adjuvant therapy for early stage, Her2-positive breast cancer and ongoing effort...
Listen to Your Patients
03 Oct 2016
Contributed by Lukas
If you are an oncologist and think that it isn't part of your job to listen to your patients talk about depression, I urge you to re-consider. As Su...
Impact of Organizational Characteristics and Process of Care on Hospital Mortality and Resource Use in Cancer Patients Admitted to Intensive Care Units
13 Sep 2016
Contributed by Lukas
Health-Related Quality of Life: Increasingly Important in the Era of Effective, Modern Myeloma Therapy
06 Sep 2016
Contributed by Lukas
Chemotherapy Induced Peripheral Neuropathy: A Novel Method of Exploration
14 Aug 2016
Contributed by Lukas
This podcast highlights the innovative methodology employed in this study to determine risk factors for chemotherapy induced peripheral neuropathy, as...
Changes in the Epidemiology of AIDS-Related Kaposi's Sarcoma and Lymphomas: How This Informs the Clinician
08 Aug 2016
Contributed by Lukas
This podcast will assist readers in understanding the clinical implications of the paper by Yanik and colleagues. The paper describes the occurrence...
Implicit Racial Bias Affects Key Aspects of Physician Communication
14 Jul 2016
Contributed by Lukas
Implicit bias affects oncologists and their patients - a few steps can help
Nivolumab Monotherapy is Safe and Active in Hematologic Malignancies
14 Jul 2016
Contributed by Lukas
This podcast is a discussion of a clinical trial by Lesokhin et al which evaluated nivolumab monotherapy in patients with relapsed or refractory hemat...
Minimizing Frailty in Cancer Survivors: A Meaningful Goal for All Ages
13 Jul 2016
Contributed by Lukas
This podcast discusses the prevalence of and risk factors associated with a phenotype of accelerated aging among ALL survivors. Measurement and implic...
1q Gain, a Prognostic Biomarker in Nephroblastoma, and What's Next?
11 Jul 2016
Contributed by Lukas
This podcast comments on two independent pediatric studies on both sides of the Atlantic showing the relevance of 1q gain in poor prognosis Wilms tumo...
Therapy Impacts Long-Term Survival for Patients in Germany With Heritable Retinoblastoma
05 Jul 2016
Contributed by Lukas
While ten-year overall survival has increased for German patients with heritable retinoblastoma, treatment modalities including radiation and/or chemo...
Dexamethasone and High-Dose Methotrexate in High-Risk B Cell Acute Lymphoblastic Leukemia—Where Should We Go From Here?
01 Jul 2016
Contributed by Lukas
The Children's Oncology Group study led by Larsen et al. showed that children and young adult patients with high-risk B cell acute lymphoblastic leuke...
Unraveling the Significance of Mismatch Repair Deficiency in Women With Endometrioid-type Endometrial Adenocarcinoma
20 Jun 2016
Contributed by Lukas
This podcast discusses the study by McMeekin and colleagues regarding their analysis of the prognostic and predictive implications of mismatch repair ...
Nodal Status After Neoadjuvant Chemotherapy Determines Prognosis in Localized Gastric Cancer
13 Jun 2016
Contributed by Lukas
A central histopathological analysis of tumor material sampled within the Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) Tr...
Restrictions on Nutrition, Social Contacts, and Pets Are Not Effective Anti-Infective Measures in Children With Acute Myeloid Leukemia
06 Jun 2016
Contributed by Lukas
Restrictions on nutrition, social contacts, and pets are not effective anti-infective measures in children with acute myeloid leukemia.
Current Status of Supplemental Screening in Dense Breasts
23 May 2016
Contributed by Lukas
This podcast will review results from screening ultrasound and tomosynthesis in women with dense breasts and will discuss current and future use of MR...
Selective Internal Radiation Therapy for Liver-Dominant Metastatic Colorectal Cancer: Time to Put the Brakes On?
11 May 2016
Contributed by Lukas
In this podcast, Dr. Andrew Ko discusses the SIRFLOX trial evaluating whether the addition of radioembolization to systemic chemotherapy confers any b...
Prognostication Based on Site of Metastatic Disease in Castration Refractory Prostate Cancer: Implications for Patient Care and Clinical Trial Design
03 May 2016
Contributed by Lukas
Impact of site of metastasis on overall survival in castration refractory prostate, and its implications on patient care and clinical trial design.
IgM-Related AL Amyloidosis: A Rare Form of a Rare Disease
25 Apr 2016
Contributed by Lukas
This podcast This JCO Podcast provides observations and commentary on the JCO article, "A European collaborative study of natural history, outcomes an...
Quality of Life: A Critical Consideration in Women Diagnosed with Ductal Carcinoma in Situ
12 Apr 2016
Contributed by Lukas
This podcast puts into context the findings from Hart and colleagues, highlighting the clinical care and research implications.
Very Late Outcomes of Wilms Tumor Survivors: British Childhood Cancer Study
29 Mar 2016
Contributed by Lukas
Web-Based Technology Can Improve Patient Understanding and Preparedness to Discuss Cancer Clinical Trials: One Step Towards a Goal of Increased Enrollment
11 Mar 2016
Contributed by Lukas
In this podcast, the article by Meropol et al. describing a randomized trial of a web-based educational tool versus a standard text-based resource is ...
How Should We Manage the Financial Toxicity of Cancer Treatment?
09 Mar 2016
Contributed by Lukas
A study by Ramsey and colleagues suggests that extreme financial distress as manifested by personal bankruptcy might be associated with worse mortalit...
Prognostication in Mantle Cell Lymphoma
29 Feb 2016
Contributed by Lukas
The Ki-67 proliferation index improves the prognostic value of the MIPI score.
Sunbelt Melanoma Trial: A Seminal Adjuvant Interferon Trial with Long Term Results
08 Feb 2016
Contributed by Lukas
Hepatocellular Carcinoma in Children and Adolescents: Time for a Strategy and a Trial
25 Jan 2016
Contributed by Lukas
An update on clinical trials that have included children with hepatocellular carcinoma
Clinical Drug Development for Non-Muscle-Invasive Bladder Cancer…Definitions Matter
25 Jan 2016
Contributed by Lukas
This podcast reviews the International Bladder Cancer Group’s recommendations regarding definitions and endpoints for the development of non-muscle-...
Race for the Cure: How differences in Race and Ethnicity Impact the Diagnosis and Survival of T-Cell Lymphoma
25 Jan 2016
Contributed by Lukas
Ethnicity’s impact on diagnosis and survival of T-cell lymphoma
Epidural Spinal Cord Compression: The Importance of Multi-disciplinary Treatment Planning
12 Jan 2016
Contributed by Lukas
Hard to RECIST: Updating and Simplifying Primary Tumor Response Guidelines for the Revised International Neuroblastoma Response Criteria (INRC)
11 Jan 2016
Contributed by Lukas
This podcast reviews the accompanying article to provide the audience an understanding of the data and rationale to support updating the INRC primary ...
Expanding Immunotheapy Benefit in Metastatic RCC
11 Jan 2016
Contributed by Lukas
Discussion of a phase I trial of the checkpoint inhibitor atezolizumab in metastatic renal carcinoma.
A New Oncogene Target in Lung Cancer: Exon 14 Alterations in the MET Gene
04 Jan 2016
Contributed by Lukas
The Evolution of the Polycythemia Vera Symptom Burden: Implications for a Changing Treatment Paradigm
30 Dec 2015
Contributed by Lukas
This podcast provides commentary on the importance of symptom assessment in Polycythemia Vera, and how this may impact therapeutic decision-making.
The Emerging Role of Gallium-68 Somatostatin-Receptor PET Imaging in Neuroendocrine Tumors
28 Dec 2015
Contributed by Lukas
This podcast describes the evolving role of Gallium-68 somatostatin-receptor PET imaging in the evaluation of patients with well-differentiated neuroe...
Dexrazoxane for childhood cancer patients – ready for prime time?
23 Dec 2015
Contributed by Lukas
Summarize the paper by Asselin et al and review the risks of therapy-related cardiomyopathy and evidence supporting dexrazoxane use in pediatric oncol...
Uterine lavage: a new approach to gynecologic cancer detection?
09 Nov 2015
Contributed by Lukas
Recent findings represent an important and exciting step in applying the rapid advance of sequencing technologies to generate molecularly-driven appro...
Hormonal Therapy is Out for Meningiomas: Time to Change Tactics?
02 Nov 2015
Contributed by Lukas
The randomized placebo controlled trial of progesterone receptor blockade showed no difference in survival, finally answering the question about hormo...
Defining the Optimal Interval for Colonoscopic Screening in Individuals with a Family History of Colorectal Cancer
02 Nov 2015
Contributed by Lukas
This podcast discusses the study by Hennink and colleagues regarding their randomized controlled trial of a 3-year versus 6-year interval for screenin...
Using the CLIC Study of Outcome in Advanced Stages of Mycosis Fungoides and Sezary Syndrome to Guide Treatment And Clinical Research
05 Oct 2015
Contributed by Lukas
This podcast reviews the current knowledge of staging and prognosis of mycosis fungoides and Sezary syndrome and evaluates the CLIC study, which aims ...
Geographic Access as a Barrier to Adjuvant Chemotherapy for Patients with Stage III Colon Cancer
24 Aug 2015
Contributed by Lukas
This podcast summarizes new evidence about the role of travel distance, oncologist density, and insurance in receipt of guideline-based chemotherapy f...
Host Factors and Lynch Syndrome Patients: Weighing Role of Obesity and Aspirin and Risk of Colorectal Cancer
17 Aug 2015
Contributed by Lukas
This podcast will discuss the association of obesity and risk of developing colorectal cancer in Lynch syndrome patients based on a manuscript by Moha...
To Stop or Not to Stop: That is the Question
17 Aug 2015
Contributed by Lukas
Normal 0 false false false EN-US JA X-NONE ...
Breast Cancer and Weight Loss: Where Do We Go from Here?
17 Aug 2015
Contributed by Lukas
The Promise and the Pitfalls of Population-Wide Screening of BRCA1 and BRCA2
17 Aug 2015
Contributed by Lukas
Intraperitoneal Therapy for Ovarian Cancer: No More Excuses
06 Aug 2015
Contributed by Lukas
This podcast will examine data on utilization, toxicity and survival outcomes with the use of intraperitoneal chemotherapy for initial treatment of ov...
Balancing Safety and Efficacy in the Treatment Hodgkin Lymphoma: Early Discontinuation of Certain Drugs Can and Should Be Done
22 Jun 2015
Contributed by Lukas
Analogous to prior analyses with ABVD, in a large series of Hodgkin lymphoma patients treated with BEACOPP, Haverkamp and colleagues from the German H...
When Toxicity and Efficacy Collide
08 Jun 2015
Contributed by Lukas
This podcast explores the complicated relationship between potency, toxicity, and duration of therapy, and how each impacts the overall efficacy of th...
First Results of Euramos I and Logistics of International Collaboration for Clinical Trials of Rare Diseases
01 Jun 2015
Contributed by Lukas
This study involved working together across oceans, regulatory bodies in various countries, different cultures in 4 cooperative groups, different stan...
Treatment Advances in Local-Regionally Advanced and Stage IVB/Recurrent Cervical Cancer: Can We Agree that More Isn't Always Better?
18 May 2015
Contributed by Lukas
The two recent papers by Kitagawa, et al and Rose, et al, give us treatment options and tools that help maximize not only the benefits of survival wit...
Androgen Deprivation Therapy for Prostate Cancer - Friend or Foe to the Psyche?
11 May 2015
Contributed by Lukas
This is a well-annotated study demonstrating that men treated with androgen deprivation therapy for prostate cancer have impaired cognitive performanc...
Building Blocks in the Case for Adjuvant Therapy in Biliary Tract Cancers
11 May 2015
Contributed by Lukas
This podcast places the results of SWOG S0809, a phase II intergroup trial of adjuvant capecitabine/gemcitabine followed by radiotherapy and concurren...
Aromatase Inhibitor Arthralgias: Identification, Treatment Options and Research Perspectives
04 May 2015
Contributed by Lukas
This is a requested commentary regarding a concurrently-published manuscript which evaluated the utility of omega-2 fatty acids for the treatment of a...
Deciphering the Heterogeneity Within EGFR-mutant Lung Cancer
20 Apr 2015
Contributed by Lukas
A meta-analysis of 7 randomized trials comparing EGFR kinase inhibitors to chemotherapy for advanced EGFR-mutant lung cancer has shown that some popul...
Precision Immunology: The Promise of Tumor Immunotherapy for the Treatment of Cancer
15 Apr 2015
Contributed by Lukas
This podcast discusses a novel immunotherapy approach using an allogeneic whole tumor cell vaccine to prime, and a recombinant antigen-encoded bacteri...
The Importance of Discussing Genetics with Every Breast Cancer Patient
14 Apr 2015
Contributed by Lukas
In summary, healthcare providers caring for breast cancer patients hopefully recognize the need for consideration of genetic testing in appropriate in...
Hematopoietic Stem Cell Transplant for Children With Acute Lymphoblastic Leukemia at BFM Centers: Comparable Results With Matched Sibling Donors and Matched Unrelated Donors
19 Mar 2015
Contributed by Lukas
Review and comments on BFM experience of ALL hematopoietic transplantation.
Is It Biology or Brawn in Ovarian Cancer Surgery?
09 Feb 2015
Contributed by Lukas
This podcasts provides perspective on a recent report evaluating disease volume and surgical complexity on post-operative tumor residuum and survival ...
Mirror Views: Reflections of Complementary Perspectives in Patient and Clinician Toxicity Reporting
05 Feb 2015
Contributed by Lukas
In this podcast, Dr. Claire Snyder discusses how patient-reported outcomes provide a critical perspective to evaluating health conditions and their tr...
Dynamic Evolution of ALK Positive Non-Small Cell Lung Cancers and Management of Associated Brain Metastases
23 Jan 2015
Contributed by Lukas
An analysis of the PROFILE studies and opportunities for treatment of ALK-rearranged non-small cell lung cancer
Prediction of Breast Cancer Risk After a Benign Breast Biopsy: A Practical Model?
21 Jan 2015
Contributed by Lukas
The development and practical utility of a model developed in the Mayo benign breast disease cohort to predict invasive breast cancer risk after benig...
Prophylactic Anticoagulation in High-Risk Metastatic Germ Cell Tumor Patients: Who Should We Treat?
21 Jan 2015
Contributed by Lukas
This JCO Podcast provides observations and commentary on the JCO article, "Large retroperitoneal lymphadenopathy as a predictor of venous thromboembol...
The Risk of Second Cancers for Patients with Endometrial and Rectal Cancer Receiving Radiation Therapy
22 Dec 2014
Contributed by Lukas
This is an oral commentary on patients with endometrial or rectal cancer, and their risk of developing second malignancies with or without radiation.
Better Outcome of Chemo-Irradiation of Head and Neck Cancer in High-Patient-Volume Institutions
08 Dec 2014
Contributed by Lukas
In a randomized RTOG study of chemotherapy concurrent with accelerated vs standard fractionated radiotherapy for head and neck cancer, it was found th...
Is There a Future for Cyclooxygenase-2 Inhibition in Non-Small Cell Lung Cancer?
01 Dec 2014
Contributed by Lukas
This podcast reviews the available data from clinical trials using cyclooxygenase-2 inhibition with chemotherapy in non-small cell lung cancer and pro...
The Treatment of Insomnia in Cancer Patients
01 Dec 2014
Contributed by Lukas
This four-arm randomized controlled trial of cognitive behavioral therapy for insomnia in cancer patients confirmed its effectiveness but did not demo...
The Biopsy Study: How the Use of Multiple Colposcopic-Directed Biopsies Improves Detection of Cervical Precancers
25 Nov 2014
Contributed by Lukas
This podcast is a review of the submitted article by Dr. Wentzensen and colleagues regarding multiple cervical biopsies at the time of colposcopy and ...
Intensified Frontline Chemoimmunotherapy with R-ACVBP May Improve Outcomes for Younger Patients with Non-Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma
25 Nov 2014
Contributed by Lukas
A secondary analysis of a multicenter randomized trial suggests that the R-ACVBP regimen may improve outcomes in younger patients with the non-germina...
A Positive Study of DTC-Guided Secondary Adjuvant Treatment in Early Breast Cancer: Ready for Prime Time?
25 Nov 2014
Contributed by Lukas
Modifying therapy based upon positive DTCs in breast cancer.
A Second Course of Radiation Therapy for Painful Osseous Metastases Improves Patient Function and Quality of Life
25 Nov 2014
Contributed by Lukas
NCIC SC.20 demonstrates that a second course of radiation for painful osseous metastases significantly improves patients quality of life and function.
Adjuvant Trastuzumab Passes the Test of Time
25 Nov 2014
Contributed by Lukas
Long-term follow up from the landmark, NCI-sponsored adjuvant trastuzumab trials confirms the clinical benefits and clinical safety of this important ...
Prognostic Value of BRAF V600 E Mutation in Papillary Thyroid Cancer
25 Nov 2014
Contributed by Lukas
This podcast provides a commentary on the association of braf mutation and thyroid cancer showing an increase risk of recurrence in patients with thyr...
Biochemotherapy: As Time Goes By?
25 Nov 2014
Contributed by Lukas
In this podcast, the results of the S0008 adjuvant intergroup trial are discussed and placed in the context of current advances in melanoma treatment.
The First Prospective Trial of Proton Therapy for Children With Rhabdomyosarcoma: What We Learn From Preliminary Results
25 Nov 2014
Contributed by Lukas
This is a prospective study of proton radiotherapy for rhabdomyosarcoma showing equivalent efficacy with photon treatment.
Intermediate Risk Pediatric Hodgkin Lymphoma: Early Response-Adapted Treatment Is Key
25 Nov 2014
Contributed by Lukas
Tailoring treatment in intermediate-risk pediatric Hodgkin lymphoma is feasible using an early response-based assessment for the omission of radiother...
Keeping Older Cancer Patients out of the Hospital: A Community Affair
25 Nov 2014
Contributed by Lukas
Given the high rate of unplanned hospitalizations in older cancer patients, multidisciplinary care is needed for outcomes improvement.
Optimal Duration of MRD Monitoring During Therapy for Childhood ALL
25 Nov 2014
Contributed by Lukas
Minimal residual disease monitoring has been very helpful in early response evaluation and risk stratification of children with acute lymphoblastic le...
Hepatitis B Reactivation in Patients Receiving Rituximab Can Be Detected Early and Managed with Antivirals
25 Nov 2014
Contributed by Lukas
This podcast describes the report of a cohort of Chinese patients with known prior hepatitis B exposure, receiving rituximab as part of their therapy ...
CT or No CT: An Important Question in Diffuse Large B-Cell Lymphoma
29 Sep 2014
Contributed by Lukas
In this paper, the authors demonstrate that only a very small percentage of patients from 2 large, prospective cohorts developed recurrent diffuse lar...
Glembatumumab Vedotin (CDX-011, CR011-vcMMAE): On The Brink Of Targeted Therapy For Triple-Negative Breast Cancer?
29 Sep 2014
Contributed by Lukas
A phase I/II study of the antibody-drug conjugate glembatumumab vedotin (CDX-011 or CR011-vcMMAE) in patients with locally advanced or metastatic brea...
Post-Transplant Cyclophosphamide for GVHD Prophylaxis: Back to the Future
29 Sep 2014
Contributed by Lukas
Conventional GVHD prophylaxis with calcineurin inhibitors has a high incidence of chronic GVHD. Kanakri et al show that post-transplant administration...
The Price Of A Drug is Not the Whole Cost
29 Sep 2014
Contributed by Lukas
Many new oncology drugs are expensive. Drug prices may not reflect the whole cost of new agents, as increases or decreases in adverse effects compared...
Cabozantinib in Advanced Prostate Cancer: Is the Therapeutic Window Too Narrow?
15 Sep 2014
Contributed by Lukas
This podcast discusses a phase 2 trial of cabozantinib in men with advanced bone-metastatic prostate cancer, using a novel method to assess bone scan ...
Fracture Risk after Cystectomy: Don't Ignore It
02 Sep 2014
Contributed by Lukas
This podcast discusses the results and practical implications of a population-based study that found an increased fracture risk after cystectomy for b...
Is Hematopoietic Stem Cell Transplantation of Value in Treating Systemic Mastocytosis?
26 Aug 2014
Contributed by Lukas
This podcast discusses the current state of knowledge regarding allogeneic transplantation as a treatment modality for advanced systemic mastocytosis.
Significant Dose Effect of Radiotherapy to the Pancreas and Risk of Diabetes Mellitus in Long-Term Hodgkin Lymphoma Survivors
26 Aug 2014
Contributed by Lukas
This study assessed diabetes mellitus risk in long-term Hodgkin lymphoma survivors, and found that a mean pancreatic tail dose of 36 Gy or higher was ...
The End of Rituximab Maintenance for Low Tumor Burden Follicular Lymphoma
26 Aug 2014
Contributed by Lukas
This podcast reviews the publication of the RESORT manuscript, and puts these results into context with the recently published Ardeshna trial of ritux...
Use of Mutational Analysis to Help Decide Whether Patients with Myelodsysplastic Syndromes Should Receive Allogeneic Hematopoietic Cell Transplant
26 Aug 2014
Contributed by Lukas
This podcast will use the study reported by Bejar and colleagues to review the role of screening for TET2, DNMT3A, and particularly TP53, mutations in...
Why are Fellows' Burnout Rates as High as Those of Practicing Oncologists?
21 Jul 2014
Contributed by Lukas
This JCO Podcast provides observations and commentary on the JCO article, "Oncology Fellows' Career Plans, Expectations and Well-Being: Do Oncology Fe...
Surprisingly Good Results in BCR-ABL1-like Pediatric Acute Lymphoblastic Leukemia: What Do They Mean?
21 Jul 2014
Contributed by Lukas
This study reports surprisingly good outcomes for children with Ph-like ALL treated on the St. Jude Total Fifteen clinical trial.
Should Corticosteroids Be Used for the Treatment of Pain, Fatigue and Loss of Appetite in Cancer Patients Receiving Opioids?
07 Jul 2014
Contributed by Lukas
Corticosteroids are recommended as part of the WHO analgesic ladder but there is limited evidence for their efficacy for the treatment of pain in canc...
Breast Reconstructions: Inequities in Access Affecting Choice and Quality
03 Jul 2014
Contributed by Lukas
The availability of reconstructive surgeons restricts the use of immediate breast reconstruction, creating unintended inequities even in a system with...
Recurrent/Metastatic Human Papillomavirus-Associated Oropharynx Cancer: What Happens When This Good Prognostic Cancer Misbehaves?
23 Jun 2014
Contributed by Lukas
This podcast describes the rising epidemic of HPV-associated oropharynx cancer, its unique demographic profile and natural history, and comments on ne...
Long Term Cardiac Safety Data from the HERA Adjuvant Trastuzumab Trial
09 Jun 2014
Contributed by Lukas
This podcast discusses the report of cardiac monitoring data from the HERA trial, places the findings in context with data from other trials, and cons...
Breast Needle Core Biopsy: The Impact Surgeons and Geography Have on Utilization and the Impact on Patient Care
09 Jun 2014
Contributed by Lukas
This is a review of breast needle biopsy for the diagnosis of breast cancer and how surgeons and geography affect utilization and the resultant impact...